ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. ASLAN Pharmaceuticals Limited is not a good value stock. ASLAN Pharmaceuticals Limited has good growth characteristics. ASLAN Pharmaceuticals Limited is not very popular among insiders. ASLAN Pharmaceuticals Limited is a mediocre stock to choose.

Aslan Pharmaceuticals Ltd. is a clinical-stage oncology-focused biopharmaceutical company, which eng...

News

Aslan Pharma To File For Liquidation, Terminates Employees; Stock Falls

RTT News - Momentum Stocks Aslan Pharmaceuticals Ltd. (ASLN) revealed Wednesday a filing for a voluntary liquidation, and termination of all the employees of the company and the fellow subsidiary Aslan Pharmaceuticals (USA...\n more…

Aslan Pharmaceuticals Begins Voluntary Liquidation

TipRanks Financial Blog Aslan Pharmaceuticals (ASLN) has released an update. Aslan Pharmaceuticals has initiated voluntary liquidation for its main operating subsidiary after a strategic r...\n more…

Aslan Pharmaceuticals commences steps to place itself in voluntary liquidation

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation

Globe Newswire Following a thorough review of all strategic alternatives, ASLAN Pharmaceuticals Pte Ltd, the sole operating subsidiary of ASLAN Pharmaceuticals, has filed for voluntary liquidation Quantuma...\n more…

ASLAN Pharmaceuticals gets delisting notice from Nasdaq

SeekingAlpha.com: All News no summary\n more…

ASLAN Pharmaceuticals Faces Nasdaq Delisting

TipRanks Financial Blog Aslan Pharmaceuticals (ASLN) has released an update. ASLAN Pharmaceuticals, a biopharmaceutical company focused on immunology, has been notified by Nasdaq of its se...\n more…